Emma Rayner
Overview
Explore the profile of Emma Rayner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
1140
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Graham V, Easterbrook L, Rayner E, Findlay-Wilson S, Flett L, Kennedy E, et al.
Viruses
. 2024 Oct;
16(10).
PMID: 39459867
Chikungunya virus (CHIKV) is a mosquito-borne alphavirus causing a debilitating febrile illness with rheumatic disease symptoms of arthralgia and arthritis. Since its spread outside of Africa in 2005, it continues...
2.
Graham V, Easterbrook L, Kennedy E, Rayner E, Findlay-Wilson S, Flett L, et al.
Viruses
. 2023 Dec;
15(12).
PMID: 38140610
Rift Valley fever virus (RVFV) is a mosquito-borne zoonotic pathogen causing disease in livestock and humans. Whilst initially restricted to the African continent, recent spread to the Arabian Peninsula has...
3.
Hunter L, Ruedas-Torres I, Agullo-Ros I, Rayner E, Salguero F
Front Vet Sci
. 2023 Oct;
10:1264833.
PMID: 37901102
Research in human tuberculosis (TB) is limited by the availability of human tissues from patients, which is often altered by therapy and treatment. Thus, the use of animal models is...
4.
White A, Tran A, Sibley L, Sarfas C, Morrison A, Lawrence S, et al.
Front Immunol
. 2023 Oct;
14:1246826.
PMID: 37881438
Tuberculosis remains a major health threat globally and a more effective vaccine than the current Bacillus Calmette Guerin (BCG) is required, either to replace or boost it. The Spore-FP1 mucosal...
5.
Larenas-Munoz F, Ruedas-Torres I, Hunter L, Bird A, Agullo-Ros I, Winsbury R, et al.
Front Vet Sci
. 2023 Oct;
10:1264200.
PMID: 37808110
Tuberculosis (TB) remains a very significant infectious disease worldwide. New vaccines and therapies are needed, even more crucially with the increase of multi-drug resistant strains. Preclinical animal models are very...
6.
Findlay-Wilson S, Easterbrook L, Smith S, Pope N, Aldridge M, Humphries G, et al.
Sci Rep
. 2023 Sep;
13(1):15419.
PMID: 37723274
No abstract available.
7.
Findlay-Wilson S, Easterbrook L, Smith S, Pope N, Aldridge M, Humphries G, et al.
Sci Rep
. 2023 Aug;
13(1):13912.
PMID: 37626085
The development of new therapies against SARS-CoV-2 is required to extend the toolkit of intervention strategies to combat the global pandemic. In this study, hyperimmune plasma from sheep immunised with...
8.
Saunders J, Gilbride C, Dowall S, Morris S, Ulaszewska M, Spencer A, et al.
EBioMedicine
. 2023 Mar;
90:104523.
PMID: 36933409
Background: The tick-borne bunyavirus, Crimean-Congo Haemorrhagic Fever virus (CCHFV), can cause severe febrile illness in humans and has a wide geographic range that continues to expand due to tick migration....
9.
Airikkala-Otter I, Frochlich J, Porkodi S, Gibson A, Gamble L, Rayner E
Indian J Community Med
. 2023 Feb;
47(4):600-603.
PMID: 36742947
Background: India carries the largest national burden for rabies globally. Coordinating large-scale canine rabies elimination programs is challenging, particularly in rural areas, where the majority of human rabies deaths occur....
10.
Sibley L, White A, Sarfas C, Gullick J, Gleeson F, Lanni F, et al.
Pharmaceutics
. 2022 Dec;
14(12).
PMID: 36559163
Innovative cross-over study designs were explored in non-human primate (NHP) studies to determine the value of this approach for the evaluation of drug efficacy against tuberculosis (TB). Firstly, the pharmacokinetics...